Home | All secondary_outcomes

[RDF data]
Secondary Outcomes #10039

Resource URI: http://static.linkedct.org/resource/secondary_outcomes/10039
rdfs:label Secondary Outcomes #10039
linkedct:measure Assess olanzapine compared with placebo in terms of improvement in clinical symptomatology, based on reductions from baseline in scores of the Clinical Global Impressions-Bipolar Version Severity of Illness scale.
linkedct:safety_issue No
is linkedct:secondary_outcomes of <http://static.linkedct.org/resource/trials/NCT00510146>
linkedct:secondary_outcomes_id 10039 (xsd:int)
linkedct:time_frame 10 weeks (includes screening period of 2-28 days)
rdf:type linkedct:secondary_outcomes